Knopp Biosciences LLC

Knopp Biosciences is a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases of high urgent unmet need. Knopp's clinical-stage molecule, dexpramipexole, is entering Phase 3 clinical studies in hypereosinophilic ...